Anticancer drugs: To the rescue?

Explore this paper's citation graph

Summary

Tumour biopsies from eight out of nine patients with gefitinib-responsive lung cancer carried these mutations, compared with none from seven nonresponders, and five out of five samples selected that had EGFR mutations were from treatment responders.

Type
review
Published
2004-06-01
Cited by
9,828
References
2
Access
Open access

Keywords

Computational biology, Computer science, Medicine, Intensive care medicine, Biology

References

Cited by

Related papers